MYC and hepatocellular carcinoma: However, the attempts to correct the effects of SAM decrease during hepatocarcinogenesis, by administration of exogenous SAM, inhibited Ha-Ras, Ki-Ras, and c-Myc expression during experimental hepatocarcinogenesis and prevented HCC development [27, 36–38] but were not curative [38].